Panacea Biotec Files Appeal Against Industrial Tribunal Award as High Court Issues Interim Order
Panacea Biotec Limited has filed an appeal before the Hon'ble High Court of Punjab and Haryana, Chandigarh, regarding a fourth award issued by the Presiding Officer (in the rank of Additional District Judge) of the Industrial Tribunal, S.A.S Nagar, Moholi. The action was taken on July 16, 2026, to challenge the remaining award among four received from the tribunal authority.The High Court has heard the initial three appeals and issued an interim order stating that no coercive steps be taken against Panacea Biotec Limited at this stage. This development follows previous legal actions initiated by the company to contest the orders passed by the Industrial Tribunal.
The awards, which were received on April 9, 2026, pertain to disputes originating from 2014 onwards. The tribunal's decisions included setting aside the transfer of 23 workmen and granting full back wages from the date of transfer, as well as awarding a reasonable wage revision for workers. Furthermore, the tribunal ordered the reinstatement of workers, excluding those who settled their disputes, with 50% back wages from the date of termination.
Panacea Biotec Limited maintains that the awards are challengeable and does not foresee any material adverse impact on its financial, operational, or other activities resulting from these specific proceedings.
| Particulars | Details |
|---|---|
| Authority Involved | Presiding Officer (in the rank of Additional District Judge) of Industrial Tribunal, S.A.S Nagar, Moholi |
| Date of Award Receipt | April 9, 2026 |
| Period Covered | From 2014 onwards |
| Summary of Award Content | Set aside transfer of 23 workmen; granted full back wages from date of transfer; awarded reasonable wage revision; ordered reinstatement of workers with 50% back wages. |
WIPRO Stock Price Movement
Wipro Limited shares rallied 1.75% today to settle at ₹177.74 in post-market trading. The stock climbed over ₹3.05 on a total volume of 11.17 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.